Research Article
Follistatin-Like 1 Protects against Doxorubicin-Induced Cardiomyopathy through Upregulation of Nrf2
Figure 1
FSTL1 expression after DOX treatment. (a, b) The mRNA level of FSTL1 in DOX-treated NRCMs (). (c) Protein expression of FSTL1 in DOX-treated NRCMs (). (d, e) The mRNA level of FSTL1 in DOX-treated hearts (). (c) Protein expression of FSTL1 in DOX-treated hearts (). vs. the NS/PBS groups. The data were analyzed using two-tailed Student’s -tests.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |